Portfolio company
Alimera Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and commercialises ophthalmic pharmaceuticals, specifically intravitreal implants for retinal diseases, supplying healthcare professionals and patients through a global distribution network.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VISUfarma
This company develops and commercialises ophthalmic pharmaceuticals and medical devices for patients with eye conditions like glaucoma and dry eye disease.
oculex-pharmaceuticals
This company develops biodegradable intraocular implants and drug delivery systems to treat retinal diseases for patients with conditions such as macular oedema.
Eyevance Pharmaceuticals
This company develops and commercialises prescription ophthalmic products to treat ocular surface diseases for ophthalmologists, optometrists and their patients.
Iveric Bio
This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.
Optos
This company manufactures ultra-widefield retinal imaging devices for eye care professionals to diagnose and manage ocular diseases.
Alliance Pharma
This international consumer healthcare company provides branded over-the-counter products and prescription medicines to patients and healthcare providers globally.
Aquesys
This company develops and manufactures ocular implants for glaucoma patients to reduce intraocular pressure through minimally invasive surgical procedures.
Ocuphire Pharma
This biopharmaceutical company develops and commercialises therapies for retinal and refractive eye disorders to treat patients with vision impairments.
